nasdaq

Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025

July 25, 2025 16:15 ET  | Source: Portage Biotech Inc. DOVER, Del., July 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech…

1 month ago

Diginex Announces Execution of Warrants Agreement, Bonus Share Issuance and Cancelation of EGM

July 25, 2025 20:00 ET  | Source: Diginex Limited LONDON, July 25, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (“Diginex” or…

2 months ago

SIMPPLE Ltd. Fully Regains Compliance with Nasdaqs Continued Listing Requirements

Singapore, July 24, 2025 (GLOBE NEWSWIRE) -- SIMPPLE Ltd. (NASDAQ: SPPL) (“SIMPPLE” or “the Company”), a leading technology provider and…

2 months ago

UPDATEBrag House Announces $15 Million Private Placement

NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- Brag House Holdings, Inc. (NASDAQ: TBH) (“Brag House” or the “Company”) the…

2 months ago

Global Defense Contractor Burke Products Selects Datavault AI for Enhanced National Defense and Aerospace Technologies Contracts

BEAVERTON, Ore., July 22, 2025 (GLOBE NEWSWIRE) -- Datavault AI Inc. (NASDAQ: DVLT), a leader in data visualization, valuation, and…

2 months ago

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

July 18, 2025 16:30 ET  | Source: Ultragenyx Pharmaceutical Inc. NOVATO, Calif., July 18, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical…

2 months ago

HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock

July 18, 2025 16:05 ET  | Source: HOOKIPA Pharma Inc. NEW YORK and VIENNA, July 18, 2025 (GLOBE NEWSWIRE) --…

2 months ago

ALT Investors Have Opportunity to Join Altimmune, Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)--$ALT--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf…

2 months ago

UNCY Investors Have Opportunity to Join Unicycive Therapeutics, Inc. Fraud Investigation With the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)--$UNCY--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf…

2 months ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

July 18, 2025 17:15 ET  | Source: Iovance Biotherapeutics, Inc. SAN CARLOS, Calif., July 18, 2025 (GLOBE NEWSWIRE) -- Iovance…

2 months ago